7
May
2024

Xizang Weixinkang Pharmaceutical Co., Ltd.

Exhibitor at CPHI North America 2024 stand 634
About Us

Weixinkang Pharmaceutical was established in 2002, officially founded in 2006, formally renamed Xizang Weixinkang Pharmaceutical Co.,Ltd. in 2013, Xizang Weixinkang Pharmaceutical Co.,Ltd. listed on the mainboard of the Shanghai Stock Exchange (stock code 603676.SH) in 2017, with 13 subsidiaries and nearly 800 employees, distributed in Beijing, Xizang, Inner Mongolia, Hainan, Jiangsu, Hong Kong，Singapore and other places. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2024
    On CPHI since
  • 500 - 999
    Employees
Company types
Pharmaceutical company
Primary activities
API Producer
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • 010-50870199
  • Website
  • 3/F, Building 4, Industrial Center, No.5,South Road, 100089, Lhasa, China
Show contact info Hide contact info
Event information
CPHI North America 2024
  • 07 May 2024 - 09 May 2024
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 634

Products Featured at CPHI North America 2024

  • Concentrate of Trace Elements Solution for Infusion (I)

    Product Concentrate of Trace Elements Solution for Infusion (I)

    Trace element additive. For use in intravenous nutritional infusions to supplement the daily needs of adults for the trace elements as chromium, iron, molybdenum, zinc, copper, manganese and selenium. 
  • Dopamine Hydrochloride Injection

    Product Dopamine Hydrochloride Injection

    Dopamine Hydrochloride Injection is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, cardiac operation, renal failure, and chronic cardiac decompensation as in congestive heart failure; the shock cannot be corre...
  • Multivitamins for Injection (13)(10/3)

    Product Multivitamins for Injection (13)(10/3)

    This product is suitable for the prevention of vitamin deficiency in adults and children aged 11 and older who are receiving parenteral nutrition. Physicians can initiate vitamin treatment without waiting for symptoms of vitamin deficiency to appear. 
  • Pediatric Multivitamins Injection (13)

    Product Pediatric Multivitamins Injection (13)

    As of 2022, Pediatric Multivitamins Injection(13) is an exclusive product in China. It is used for the prevention and treatment of pediatric patients aged under 11 with vitamin deficiency for parenteral nutrition, especially in newborns/NICU, critically ill patients, pediatric surgery patients, and pediatr...
  • Succinyl Gelatin Injection

    Product Succinyl Gelatin Injection

    Succinyl Gelatin Injection is a plasma volume substitute. This means, it replaces fluid lost from the circulation. It is used to replace blood and body fluid, which have been lost as a result of, for example, an operation, an accident or a burn. It can be used instead of, or as well as, a blood transfusion...